(S)-4-Benzyl-3-(2-chloroacetyl)oxazolidin-2-one, 98+%, 5g

Toluhydroquinone, min 99%, pour synthèse, 500 g, emballage plastique.

1-(4-Fluoro-phenyl)-1H-pyrazole-4-carboxylic acid, 99%, 1g

3-Bromo-4-chlorobenzoic acid, 97.0%, 100g

(S)-4-(Benzo[b]thiophen-3-yl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 97%, 250mg

Lamelles de protection siliconées, 12 x 12 mm 1000 pcs

(S)-1-(4-(Difluoromethoxy)phenyl)ethan-1-amine hydrochloride, 95%, 100mg

{2-[(2-methyl-2-propen-1-yl)oxy]phenyl}methanol, 95.0%, 5g

1-(3-NITROPYRIDIN-2-YL)AZEPANE, 97.0%, 1g

Betamethasone disodium phosphate, 10g

4-{[4-(diethylamino)phenyl]methylidene}-1,2,3,4-tetrahydroacridine-9-carboxylic acid, 95%, 250mg

2-Amino-3-bromo-5,6-dimethylpyridine, 99.0%, 5g

N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 250mg